Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Hardwarex
|
December 30, 2025
Lensless light guide-coupled LED illumination for low-cost microscopy
Fox Avery, Thomas Geer, Dirk Albrecht
Digestive Diseases (Basel, Switzerland)
|
May 16, 2006
Treatment of gastrointestinal stromal tumor with imatinib mesylate: a retrospective single-center experience in Heidelberg
Bernd Kasper, Birgit Kallinowski, Thomas Herrmann, et al.
Journal of Cancer Research and Clinical Oncology
|
May 16, 2018
Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional study
Florian Nolte, Holger Nückel, Burkhard Schmidt, et al.
Oncology
|
July 16, 2005
Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer
M Karthaus, Harald Ballo, Wolgang Abenhardt, et al.
Haematologica
|
March 3, 2009
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
Susanne Schnittger, Ulrike Bacher, Claudia Haferlach, et al.
Annals of Hematology
|
October 4, 2023
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
European Journal of Haematology
|
July 7, 2025
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical Routine
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
June 5, 2013
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma
Britta Auel, Hartmut Goldschmidt, Thomas Geer, et al.
Journal of Cancer Research and Clinical Oncology
|
February 16, 2017
Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care
Carl Christoph Schimanski, Frank Staib, Thomas Göhler, et al.
British Journal of Cancer
|
October 14, 2025
Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)
Manfred P Lutz, Nikolaus Ansorge, Gleb Barmashenko, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Hardwarex
|
December 30, 2025
Lensless light guide-coupled LED illumination for low-cost microscopy
Fox Avery, Thomas Geer, Dirk Albrecht
Digestive Diseases (Basel, Switzerland)
|
May 16, 2006
Treatment of gastrointestinal stromal tumor with imatinib mesylate: a retrospective single-center experience in Heidelberg
Bernd Kasper, Birgit Kallinowski, Thomas Herrmann, et al.
Journal of Cancer Research and Clinical Oncology
|
May 16, 2018
Tolerability and efficacy of deferasirox in patients with transfusional iron overload: results from a German 2-year non-interventional study
Florian Nolte, Holger Nückel, Burkhard Schmidt, et al.
Oncology
|
July 16, 2005
Prospective, double-blind, placebo-controlled, multicenter, randomized phase III study with orally administered budesonide for prevention of irinotecan (CPT-11)-induced diarrhea in patients with advanced colorectal cancer
M Karthaus, Harald Ballo, Wolgang Abenhardt, et al.
Haematologica
|
March 3, 2009
Detection of JAK2 exon 12 mutations in 15 patients with JAK2V617F negative polycythemia vera
Susanne Schnittger, Ulrike Bacher, Claudia Haferlach, et al.
Annals of Hematology
|
October 4, 2023
Real-world analysis of ruxolitinib in myelofibrosis: interim results focusing on patients who were naïve to JAK inhibitor therapy treated within the JAKoMo non-interventional, phase IV trial
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
European Journal of Haematology
|
July 7, 2025
Final Results From a Large, Non-Interventional, Phase 4 Study of Ruxolitinib for the Treatment of Myelofibrosis in Clinical Routine
Steffen Koschmieder, Susanne Isfort, Clemens Schulte, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion
|
June 5, 2013
Treatment with Thalidomide and Cyclophosphamide (TCID) is Superior to Vincristine (VID) and to Vinorelbine (VRID) Regimens in Patients with Refractory or Recurrent Multiple Myeloma
Britta Auel, Hartmut Goldschmidt, Thomas Geer, et al.
Journal of Cancer Research and Clinical Oncology
|
February 16, 2017
Dermatux: phase IV trial of Cetuximab plus FOLFIRI in first-line metastatic colorectal cancer receiving a pre-defined skin care
Carl Christoph Schimanski, Frank Staib, Thomas Göhler, et al.
British Journal of Cancer
|
October 14, 2025
Predictive criteria for overall survival and treatment duration of 2nd-line chemotherapy in patients with advanced pancreatic adenocarcinoma (AIO-PAK-0216)
Manfred P Lutz, Nikolaus Ansorge, Gleb Barmashenko, et al.
Page
of 3